Top pharma companies by cardio revenue worldwide 2023 and 2028
This statistic depicts the global top 10 companies for cardiology-related drug sales in 2023 and a forecast for 2028. In 2023, Novartis generated 7.8 billion U.S. dollars of heart drug revenues worldwide. The Swiss company is projected to keep its leading position in this field until 2028. Cardiovascular diseases are amomng the most common causes of death in general. Risk for heart disease increases with diabetes, obesity, poor diet, and a lack of physical activity.